BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7748076)

  • 1. Endometrial squamous metaplasia. An unusual response to progestin therapy of hyperplasia.
    Miranda MC; Mazur MT
    Arch Pathol Lab Med; 1995 May; 119(5):458-60. PubMed ID: 7748076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Wheeler DT; Bristow RE; Kurman RJ
    Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.
    Amezcua CA; Lu JJ; Felix JC; Stanczyk FZ; Zheng W
    Gynecol Oncol; 2000 Nov; 79(2):169-76. PubMed ID: 11063639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
    Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pathological responses of progestin therapy for non-atypical endometrial hyperplasia: a prospective study.
    Rattanachaiyanont M; Angsuwathana S; Techatrisak K; Tanmahasamut P; Indhavivadhana S; Leerasiri P
    J Obstet Gynaecol Res; 2005 Apr; 31(2):98-106. PubMed ID: 15771634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endometrial atypical complex hyperplasia with extensive squamous metaplasia: two cases].
    Hannachi Sassi S; Dhouib R; Abbes I; Braham E; Mrad K; Driss M; Ben Hamida N; Ben Romdhane K
    Ann Pathol; 2008 Jun; 28(3):233-6. PubMed ID: 18706369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of bcl-2 is a potential marker of the efficacy of progestin therapy in the treatment of endometrial hyperplasia.
    Amezcua CA; Zheng W; Muderspach LI; Felix JC
    Gynecol Oncol; 1999 Apr; 73(1):126-36. PubMed ID: 10094893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia.
    Rubatt JM; Slomovitz BM; Burke TW; Broaddus RR
    Gynecol Oncol; 2005 Nov; 99(2):472-6. PubMed ID: 16099019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives.
    Shen ZQ; Zhu HT; Lin JF
    Obstet Gynecol; 2008 Aug; 112(2 Pt 2):465-7. PubMed ID: 18669766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial hyperplasia involving endometrial polyps: report of a series and discussion of the significance in an endometrial biopsy specimen.
    Kelly P; Dobbs SP; McCluggage WG
    BJOG; 2007 Aug; 114(8):944-50. PubMed ID: 17565613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy.
    Penner KR; Dorigo O; Aoyama C; Ostrzega N; Balzer BL; Rao J; Walsh CS; Cass I; Holschneider CH
    Gynecol Oncol; 2012 Mar; 124(3):542-8. PubMed ID: 22079678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices.
    Perino A; Quartararo P; Catinella E; Genova G; Cittadini E
    Acta Eur Fertil; 1987; 18(2):137-40. PubMed ID: 3115027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
    Cao DY; Yu M; Yang JX; Shen K; Huang HF; Cheng NH; Sun ZY; Deng CY; Yu Q; He FF
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):519-22. PubMed ID: 24284224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hormone therapy on the endometrium.
    Deligdisch L
    Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of gestagens in prevention and therapy of endometrial hyperplasia].
    Römer T
    Zentralbl Gynakol; 1995; 117 Suppl():14-8. PubMed ID: 8571687
    [No Abstract]   [Full Text] [Related]  

  • 17. The ability of endometrial biopsies with atypical complex hyperplasia to guide surgical management.
    Miller C; Bidus MA; Pulcini JP; Maxwell GL; Cosin JA; Rose GS
    Am J Obstet Gynecol; 2008 Jul; 199(1):69.e1-4. PubMed ID: 18241812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of progestins in the menopausal patient: dosage and duration.
    Gambrell RD
    J Reprod Med; 1982 Aug; 27(8 Suppl):531-8. PubMed ID: 7131446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial metaplasia associated with endometrial carcinoma.
    Kaku T; Tsukamoto N; Tsuruchi N; Sugihara K; Kamura T; Nakano H
    Obstet Gynecol; 1992 Nov; 80(5):812-6. PubMed ID: 1407921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
    Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.